News | Artificial Intelligence | November 13, 2018

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

Deep learning algorithms designed for faster scans and reduced radiation dose

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

November 13, 2018 — At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical will showcase SubtlePET, its artificial intelligence (AI)-powered technology. SubtlePET allows hospitals and imaging centers to deliver a faster and safer patient scanning experience, while enhancing exam throughput and provider profitability. The software is currently under U.S. Food and Drug Administration (FDA) 510k review and in pilot use in multiple university hospitals and imaging centers in the U.S. and abroad.

SubtlePET leverages AI to allow hospitals and imaging centers to accelerate positron emission tomography (PET) scan times four-fold or reduce PET radiation dose by up to 75 percent, according to the company.

A second product pending FDA submission is SubtleMRI, which allows imaging centers to significantly accelerate magnetic resonance imaging (MRI) scans. Subtle Medical’s focus on image acquisition and workflow differentiates it from most AI imaging companies, which are focusing on post-processing and computer-aided diagnosis.

Subtle Medical technology utilizes deep learning algorithms that integrate seamlessly with any original equipment manufacturer (OEM) PET and MRI scanners to enhance images during acquisition without any interruption or alteration in the imaging specialists’ workflow.  The result is shorter scan duration or less exposure to radiation, which is particularly beneficial for children and those undergoing repeat PET exams.

In March 2018, Subtle Medical received the NVIDIA Inception Award Top Healthcare+AI Startup Globally from among over 3,000 AI contenders. The company was also selected as the first AI+healthcare startup for Bessemer Venture Partner’s Deep Health Seed Program.

Subtle Medical’s core technology was developed at Stanford University.  The company has licensed multiple patented technologies invented by the founders at Stanford as well as medical imaging datasets acquired during clinical research at Stanford radiology labs.

At RSNA 2018, Subtle Medical’s co-founders will be participating in research and industry presentations along with other academic collaborators from Stanford. Presentations include:

Lunch and Learn: Thinking Faster, Safer, & Smarter: How You Can Use AI to improve MR and PET Imaging Efficiency, Patient Satisfaction, and Safety

Greg Zaharchuk, M.D., Ph.D. |Chris Hess, M.D., Ph.D. | Paul Chang, MS, M.D. | Michael Brant-Zawadzki, M.D., FACR

Wednesday 12:30-1:30 PM | LL33  

 

Machine Learning Theater: AI Improves Imaging Workflow for MR and PET Exams: Faster, Safer, and Smarter

Greg Zaharchuk, M.D., Ph.D. |Enhao Gong, Ph.D.

Monday 12:00-12:20 PM | ML23

 

Evaluation of Deep-Learning-Based Technology for Reducing Gadolinium Dosage in Contrast-Enhanced MRI Exams

Enhao Gong, Ph.D. | Jonathan Tamir, BSC | John Pauly | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Physics (MR: New Techniques, Systems, Evaluation)

Monday 10:30-12:00 PM | SSC12 | Presentation 9 of 9

 

Does 18F-FDG Dose Reduction for PET/MRI Affect Treatment Response Assessment of Lymphomas and Sarcomas?

Ketan Yerneni |Anne Muehe, M.D. | Praveen Gulaka, Ph.D. | K. Elizabeth Hawk, M.D., Ph.D. | Ashok Joseph Theruvath, M.D. | Heike Daldrup-Link, M.D.

Monday 12:45-1:15 PM | PD218-SD-MOB4

 

Stroke Outcome Prediction from Meta Information Available at Patient Admission

Yuan Xie | Bin Jiang | Enhao Gong, Ph.D. | Ying N. Li | Guangming Zhu | Bo Zhou | Patrik Michel | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Neuroradiology Series: Stroke

Wednesday 8:30-12:00 PM | RC505 | Presentation 10 of 12

 

Deep Learning Segmentation for Detection of Brain Metastases in the Small Data Regime

Daniel L. Rubin, M.D., MS | Greg Zaharchuk, M.D., Ph.D. | Michael Iv, M.D. | Rhea Singh

Neuroradiology (Dots and Dashes: Image Analysis in Neuroradiology)

Thursday 10:30-12:00 PM | SSQ15 | Presentation 8 of 9

For more information: www.subtlemedical.com

 

Related Content

News | PET-CT | June 10, 2021
June 10, 2021 — Bringing the power of...
Richard Ernst was considered the father of nuclear magnetic resonance imaging (MRI)
News | Magnetic Resonance Imaging (MRI) | June 10, 2021
June 10, 2021 — The Washington Post has reported that Richard R.
The U.S. Food and Drug Administration (#FDA) approved #Aduhelm (#aducanumab) for the treatment of #Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.

Getty Images

News | PET Imaging | June 07, 2021
June 7, 2021 — The U.S.
According to a pilot study published in ARRS’ American Journal of Roentgenology (AJR), the flexed elbow valgus external rotation (FEVER) view can improve magnetic resonance imaging (MRI) evaluation of the ulnar collateral ligament (UCL) in Major League Baseball (#MLB) pitchers.

(A) Side view of volunteer demonstrating proper positioning for FEVER view; note elevated flexed elbow and sandbags to induce valgus stress. Elbow coil is not included in image.

(B) Coronal fat-saturated proton-density weighted MR image in FEVER view in 20-year-old male pitcher shows normal anterior bundle of UCL (blue arrow) and 2.9 mm UT articular width.

News | Magnetic Resonance Imaging (MRI) | June 04, 2021
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
Chest X-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients. Image courtesy of University of Waterloo

Chest X-rays used in the COVID-Net study show differing infection extent and opacity in the lungs of COVID-19 patients. Image courtesy of University of Waterloo

News | Coronavirus (COVID-19) | June 03, 2021
June 3, 2021 — Artificial intelligence
A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Ultrasound Imaging | June 01, 2021
June 1, 2021 — According to an open-access Editor's Choice article in ARRS' ...